PathCision Medicine develops precision biologics for metastatic cancer using translational medicine and machine learning.
PathCision Medicine has raised $200K in total funding. The most recent round was Seed. The last funding was announced in February 2024.
PathCision Medicine is headquartered in Watertown, United States.
PathCision Medicine develops precision biologics for metastatic cancer using translational medicine and machine learning.
PathCision Medicine is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PathCision Medicine — Funding & Investors." VCBacked, February 20, 2024, https://www.vcbacked.co/company/pathcision-medicine. Accessed August 14, 2026.
VCBacked. (2024). PathCision Medicine — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/pathcision-medicine
{{cite web |title=PathCision Medicine — Funding & Investors |url=https://www.vcbacked.co/company/pathcision-medicine |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated